Entrada Therapeutics, Inc. (TRDA) vs Yarrow Bioscience, Inc (YARW)
Entrada Therapeutics, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Entrada Therapeutics, Inc. and Yarrow Bioscience, Inc are of similar size ($246.0M and $242.2M). Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −94.1%. Entrada Therapeutics, Inc. has the higher net margin (−3,537.7% vs −3,881.5%) and the lower return on invested capital (−1,060.2% vs 0.00%). Across the 15 metrics below, Yarrow Bioscience, Inc leads on 8 and Entrada Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | TRDA | YARW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (3,767.07%) | (4,134.44%) | 0.00% |
| Net margin | (3,537.73%) | (3,881.54%) | 0.00% |
| Free cash flow margin | (2,867.07%) | (3,513.07%) | 0.00% |
| Return on equity | (54.09%) | (61.40%) | (57.72%) |
| Return on assets | (44.35%) | (54.77%) | (49.22%) |
| Return on invested capital | (1,060.24%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack